禽致病性大肠杆菌Ⅰ型菌毛fimH基因缺失突变株的构建及部分生物学特性的分析

基于禽大肠杆菌Ⅰ型菌毛黏附素fimH基因的已知序列,利用λ噬菌体的Red重组系统构建禽致病性大肠杆菌国内分离株A2(血清型O2:K89)Ⅰ型菌毛黏附素fimH基因缺失突变株A2△fimH::Cat,在二次重组中利用携带能够表达FLP位点特异性重组酶的质粒pCP20(温度敏感性)以去除上述缺失突变株中抗性基因标志,结合PCR扩增和测序结果,证明fimH基因缺失株.A2△fimH的正确构建.通过fimH基因互补试验使A2△fimH缺失突变株恢复了与野生株具有相同的凝集活性.红细胞和酵母细胞凝集试验结果表明,野生株呈现良好的凝集效果,并能被0.5%甘露糖完全抑制,而A2△fimH缺失突变株未呈现任何凝集现象.体外生长试验结果表明,在同样的培养条件下,A2△fimH缺失突变株生长周期的各个阶段都要稍慢于野生株.禽致病性大肠杆菌国内分离株Ⅰ型菌毛黏附素fimH基因缺失突变株成功构建,为进一步深入研究禽大肠杆菌Ⅰ型菌毛与机体相互作用的分子机制,肠道外感染的致病机理及对国内禽大肠杆菌病的防控策略奠定了一定基础.     

禽致病性大肠杆菌gspL基因缺失株构建及生物学特性

【目的】研究gsp L基因缺失对禽致病性大肠杆菌(Avian pathogenic Escherichia coli,APEC)生物学特性的影响。【方法】利用Red重组方法构建禽致病性大肠杆菌DE17株的gsp L缺失株;分析野生株与缺失株的生长特性、黏附和入侵DF1细胞的差异;采用荧光定量PCR的方法比较野生株和缺失株毒力基因转录水平的变化;比较野生株与缺失株的半数致死量(LD50)差异。【结果】gsp L缺失不影响DE17的生长特性,但其黏附和入侵DF1细胞能力显著下调。荧光定量PCR检测结果表明,缺失株毒力基因lux S,pfs,fyu A和iss转录水平明显上调,tsh的转录水平明显下调,而vat,ibe A,stx2f和omp A的转录水平无显著变化;LD50检测结果表明,缺失株比野生株毒力增强了12倍。【结论】gsp L基因的缺失不影响禽致病性大肠杆菌的生长特性,但能减弱其黏附和入侵能力,且可以正调控禽致病性大肠杆菌部分毒力基因的转录水平,推测gsp L基因可能与APEC对宿主的致病性有关。     

猪链球菌2型菌毛骨架蛋白编码基因SSU2101敲除突变株的构建及其生物学功能

利用同源重组基因敲除方法构建猪链球菌2型(Streptococcus suis serotype2,S.suis2)中国强毒株05ZYH33菌毛骨架蛋白(Backbone protein,BP)编码基因SSU2101敲除突变株。采用引物特异性PCR分析、Southern杂交及RT-PCR等方法鉴定,证实成功构建了BP基因缺失突变株。生物学特性显示,突变株的菌落形态、溶血活性以及染色特性方面与野生株之间均无明显差异。小鼠致病性试验结果显示,突变株的毒力比野生株显著减弱。研究结果提示菌毛在S.suis2感染致病过程中起重要作用,为系统研究S.suis2菌毛分子装配机制及其生物学功能奠定了基础。     

pagP基因对禽致病性大肠杆菌抗菌肽抗性和致病性的影响

【目的】禽致病性大肠杆菌(Avian pathogenic Escherichia coli,APEC)不仅严重影响全球的养禽业,对人类公共健康也造成巨大的潜在威胁。pag P基因在细菌的抗菌肽抗性和致病性方面发挥重要作用,但关于pag P基因在APEC中的功能尚不清楚。本文构建禽致病性大肠杆菌pag P基因缺失株,对缺失株的抗菌肽抗性和致病性进行研究。【方法】利用Red重组系统构建APEC的pag P基因缺失株,然后利用回复质粒构建回复株。研究pag P基因对细胞黏附与入侵、生物被膜形成能力、外膜渗透性、抗菌肽敏感性、致病性等方面的影响。【结果】成功构建pag P基因缺失株和回复株,抗菌肽抗性试验发现pag P基因缺失株对多粘菌素B、鸡β-防御素2(AVBD2)的敏感性显著增加(P0.01),致病性试验结果表明pag P基因缺失株的毒力显著降低(P0.01)。【结论】APEC的pag P基因对AVBD2的敏感性和APEC的致病性密切相关,为深入研究pag P基因的功能及调控作用奠定了基础。     

双组分系统rcsC基因影响禽致病性大肠杆菌的致病性及相关生物学特性

【目的】双组分系统Rcs感受外界环境变化,并调控细菌的适应性及生存等。本文探讨Rcs双组分系统传感器激酶RcsC对禽致病性大肠杆菌(avian pathogenic Escherichia coli,APEC)相关生物学特性及致病性的影响。【方法】采用Red同源重组的方法构建rcsC基因缺失株,并利用互补质粒构建互补株,然后比较野生株、基因缺失株与互补株的生长特性、运动性、生物被膜、凝集沉淀能力、致病力及毒力基因转录水平的差异。【结果】rcsC基因缺失不影响APEC的生长速度,然而,缺失RcsC导致APEC的运动能力升高、生物被膜形成能力降低和凝集能力增强。凝集试验结果显示rcsC基因有助于APEC的凝集沉降。细胞黏附入侵结果表明,rcsC在APEC侵袭DF-1细胞过程中发挥作用,而对黏附能力无影响。动物感染试验结果表明rcsC基因缺失能显著降低APEC的毒力。荧光定量PCR检测结果表明,rcsC基因缺失株中ompA、aatA、fyuA和luxS基因的转录水平均显著降低,而fimC和tsh基因的转录水平显著升高。【结论】RcsC参与调控APEC的运动性、生物被膜形成、凝集沉降和致病力。     

VI型分泌系统2核心组分VgrG对禽致病性大肠杆菌致病性的影响

【目的】构建禽致病性大肠杆菌(Avian pathogenic Escherichia coli,APEC)VI型分泌系统2(Type VI secretion system 2,T6SS2)结构基因vgrG缺失株,研究其对APEC生物学特性及致病性的影响。【方法】通过Red同源重组方法构建DE719菌株vgrG基因缺失株,并利用低拷贝质粒pSTV28构建互补株。比较分析野生株、缺失株与互补株的生长特性、运动性、生物被膜形成能力、黏附侵袭能力、动物致病力等差异。【结果】vgr G基因缺失不影响DE719的生长速度、运动能力及生物被膜形成能力。致病性试验表明缺失vgrG导致体内定殖能力及致病力显著下降,然而对DF-1细胞的黏附能力增强。【结论】T6SS2核心组分VgrG在APEC感染过程中发挥重要作用,为了解APEC的致病作用提供参考。     

禽致病性大肠杆菌IMT5155 疑似毒力基因在人源及动物源大肠杆菌中的分布

[目的]检测禽致病性大肠杆菌IMT5155自分泌黏附素基因等具有代表性的疑似毒力基因在不同来源大肠杆菌中的分布,为进一步研究其致病机理提供依据.[方法]采用PCR和Dot blot,检测疑似毒力基因在不同地区(101株大肠杆菌中国分离株和121株大肠杆菌德国分离株)、不同来源(人源、禽源及猪源)大肠杆菌中的分布,并分析其和大肠杆菌系统进化分群的关系.[结果]自分泌黏附素基因B11等11个疑似毒力基因在禽致病性大肠杆菌中分布率较高,阳性率分别为:A1 36.4%(32/88)、A8 53.4%(47/88)、A1063.6%(56/88)、B1137.5%(33/88)、F3 59.1%(52/88)等,且疑似毒力基因主要存在于大肠杆菌B2进化群中.值得注意的是,D1、E9和F11基因片段在新生儿脑膜炎大肠杆菌中有较高的分布率,分别为60%(6/10)、80%(8/10)和90%(9/10),而在新生儿脑膜炎大肠杆菌中未检测到B11基因.[结论]自分泌黏附素B11等疑似毒力基因与禽致病性大肠杆菌关系密切,但疑似毒力基因D1、E9和F11与新生儿脑膜炎大肠杆菌密切相关,提示禽致病性大肠杆菌可能是新生儿脑膜炎大肠杆菌的毒力基因储库.     

空泡形成毒素影响禽致病性大肠杆菌的生物学特性及致病性

摘要:【目的】构建禽致病性大肠杆菌(Avian pathogenic Escherichia coli,APEC)菌株APEC-O1空泡形成毒素(Vacuolating autotransporter toxin,Vat)基因缺失株,研究该基因对APEC-O1生物学特性及致病性的影响。【方法】采用Red同源重组的方法构建vat 缺失株,并利用低拷贝质粒pSTV28构建互补株,然后比较野生株、vat缺失株与互补株在生长特性、运动性、凝集沉淀能力、生物被膜、致病性等生物学特性的差异。【结果】vat基因缺失不影响APEC-O1的生长速度及抗环境压力能力,但缺失vat导致APEC-O1运动能力增强,而使生物被膜形成能力、凝集沉降能力、致病力、体内存活能力均显著性减弱。【结论】Vat缺失影响APEC-O1运动能力、凝集沉淀能力、生物被膜形成能力及致病力,为全面了解Vat 的致病作用提供参考。     

rmlA 基因缺失影响禽致病性大肠杆菌的生物被膜形成

【目的】构建禽致病性大肠杆菌(Avian pathogenic Escherichia coli,APEC)rmlA基因缺失株,研究该缺失株的生物学特性。【方法】利用Red重组系统构建rmlA缺失株;比较野生株与缺失株在生长特性、运动性和生物被膜形成能力等方面的差异;运用Real-time PCR技术,比较野生株与rmlA缺失株对APEC部分毒力基因转录的影响。【结果】rmlA缺失株,不影响APEC的生长和运动特性,但生物被膜形成能力显著增强,且使luxS、irp2基因转录水平分别上调2倍、1.8倍,iucD、fyuA则下调25倍。【结论】APEC的rmlA基因可以影响禽致病性大肠杆菌的生物被膜形成能力及部分毒力基因的转录水平;而对APEC的生长、运动特性没有影响。     

大肠杆菌K88ac菌毛操纵子fae全基因的克隆、表达及生物学活性初步研究

目的：在体外克隆和表达猪肠产毒性大肠杆菌（ETEC）K88ae菌毛操纵子,触结构基因,并检测重组菌毛的相关生物学活性。方法：利用长PCR技术以猪ETECK88ae株C83902基因组DNA为模板扩增编码K88菌毛操纵子触基因,克隆入表达质粒载体pBR322,构建和筛选重组质粒pBR322-fae,转化至不含任何菌毛的大肠杆菌EP株;电镜观察重组菌表面菌毛表达情况;用热抽提法提纯表达的重组菌毛;用纯化菌毛免疫小鼠制备高效价抗血清;用SDS-PAGE和Western blot检测重组菌毛的抗原性,用细胞黏附和黏附抑制试验检测其生物学活性。结果和结论：在电镜下观察到重组菌表面大量表达K88ae菌毛,该重组菌与兔抗K88ae菌毛单因子阳性血清、鼠抗K88ac菌毛单克隆抗体均产生凝集反应;纯化菌毛经SDS-PAGE,结构单位菌毛呈单一的相对分子质量约26×10^3的蛋白条带;纯化菌毛免疫小鼠后可制备出高效价的鼠抗血清,玻板凝集试验和Western blot结果表明体外表达的K88ae菌毛具有与K88ae野生菌毛相同的抗原性;猪小肠上皮细胞系黏附和黏附抑制实验结果表明重组EP菌和野生菌株一样具有较强的黏附猪小肠上皮细胞系的能力,而且提纯重组菌毛制备出的鼠抗血清能有效抑制上述重组菌或野生菌株对猪小肠上皮细胞系的黏附结合。     

地衣芽胞杆菌FLP/FRT基因编辑系统的构建及验证

地衣芽胞杆菌有效的基因编辑工具有限,为了拓展和丰富其基因编辑手段,在地衣芽胞杆菌中构建一个抗性标记可重复使用的FLP/FRT基因编辑系统,并通过敲除α-淀粉酶基因amyL、蛋白酶基因aprE及敲入外源透明颤菌血红蛋白基因vgb对该系统进行初步验证。首先以温敏质粒pNZT1为载体分别构建amyL和aprE基因敲除质粒pNZTT-AFKF和pNZTT-EFKF,两个敲除质粒各自包含针对目标基因的同源臂、抗性基因及同向的FRT位点;将敲除质粒转化地衣芽胞杆菌并经过两次同源交换过程实现目标基因的敲除;最后导入一个FLP重组酶表达质粒通过FLP/FRT系统的重组作用介导抗性基因的回收。为进一步验证本系统的实用性及编辑效率,构建了包含透明颤菌血红蛋白编码基因vgb表达盒及基因组丙酮酸甲酸裂解酶编码基因pflB敲除盒的重组质粒pNZTK-PFTF-vgb,并以此进行外源基因vgb在基因组上的定向敲入。结果显示,成功敲除amyL及aprE并回收了抗性标记卡那霉素基因,敲除后淀粉酶活和蛋白酶活分别减少95.3%和80.4%;vgb基因成功整合入基因组pflB位点并回收了抗性标记四环素基因,并利用荧光定量PCR技术检测到vgb的整合表达。文中首次建立了一个适用于地衣芽胞杆菌的、抗性标记可重复使用的FLP/FRT基因编辑系统,并进行了基因敲除及基因敲入验证,为地衣芽胞杆菌遗传改造提供了良好的方法参考。     

DNA重组酶FLP原核表达与多步法纯化及其活性检测

DNA重组酶FLP存在于酵母2μ质粒上,能识别34bp的FRT位点,并根据2个FRT位点的相对方向完成位点间DNA序列的交换、重组、删除与逆转,在现代分子生物学理论研究与基因工程技术开发中具有广泛应用。构建了在原核大肠杆菌中高效表达FLP重组酶的表达载体pQE32-flpe并建立起相应的原核高效表达体系,在原核细菌大肠杆菌M15菌株中实现FLP酶蛋白的高效表达,同时建立了相应的纯化方法。纯化时先用硫酸铵沉淀法富集FLP酶蛋白,经透析脱盐后再用镍离子鳌合微柱(0.5~1.0mL)亲合层析梯度洗脱的方法获得纯化的FLP酶蛋白。通过构建含有2个方向相同的FRT序列位点的质粒pUC18-FRT-gfp-FRT和含有1个FRT位点的表达载体pET30a-FRT,并分别以其为底物来检测FLP重组酶的删除、交换与重组功能的活性。结果表明,该方法不仅能有效表达FLP酶蛋白,并能行之有效地纯化FLP酶蛋白,以及检测纯化的FLP酶蛋白对DNA序列的删除、重组与交换功能。该方法简单易行并能获得有活性的FLP酶蛋白,为深入研究其机理以及研发相应的DNA重组技术提供重要参考。     

在基于BAC的EB病毒基因组中引入突变

为了在Epstein-Barr病毒(EBV)172kb的基因组中引入突变以研究基因功能,建立了一种简单有效的基因操作方法.在载体pcDNA3.1( )上操作,将两端含有重组蛋白FLP识别位点(FRT)的卡那霉素筛选标记基因(kan)与鼻咽癌(NPC)来源的、包含LMP1基因全长ORF的gDNA"无缝"连接(无外源序列插入).连接后的kan-LMP1线性DNA片段经转化、由λ噬菌体中redαβγ系统介导在E.coli中发生同源重组(ET克隆),用kan-LMP1替代了BAC-EBV(p2089)中相应的LMP1基因区域,然后经过重组蛋白FLP对FRT-kan-FRT特异性的识别,切除了引入的kan基因,留下一个69bp的FRT"疤痕".通过抗性筛选和对菌液进行PCR扩增可以鉴定突变子.这种经改进并程序化的方法.也适应于引入其它突变或在其它BAC-疱疹病毒基因组中引入突变.     

利用λRed重组系统敲除伤寒沙门氏菌rfaH基因

目的：利用λRed重组系统敲除伤寒沙门氏菌的rfaH基因。方法：以伤寒沙门氏菌（Salmonella typhi Ty2,S.ty2）基因组为模板扩增得到的同源臂,与两端带有FRT位点的卡那霉素抗性基因片段共同构建同源重组载体;以重组载体为模板扩增打靶片段,将其转化S.ty2;在抗生素压力和λRed重组系统帮助下,打靶片段和菌体基因组发生同源重组,通过卡那抗性筛选得到带有抗性标记的重组菌;转入重组酶表达质粒pCP20以去除抗性标记,得到保留单一FRT位点的突变菌株;通过PCR鉴定重组菌,并经透射电子显微镜分析表型。结果：在S.ty2中敲除了rfaH基因,经PCR扩增和序列测定正确;初步的表型分析表明突变体的鞭毛合成显著减少。结论：获得了S.ty2突变株,为将沙门氏菌进一步减毒成为疫苗表达载体奠定了基础。     

FLP-mediated recombination in the vector mosquito, Aedes aegypti.

The activity of a yeast recombinase, FLP, on specific target DNA sequences, FRT, has been demonstrated in embryos of the vector mosquito, Aedes aegypti. In a series of experiments, plasmids containing the FLP recombinase under control of a heterologous heat-shock gene promoter were co-injected with target plasmids containing FRT sites into preblastoderm stage mosquito embryos. FLP-mediated recombination was detected between (i) tandem repeats of FRT sites leading to the excision of specific DNA sequences and (ii) FRT sites located on separate plasmids resulting in the formation of heterodimeric or higher order multimeric plasmids. In addition to FRT sites originally isolated from the yeast 2 microns plasmid, a number of synthetic FRT sites were also used. The synthetic sites were fully functional as target sites for recombination and gave results similar to those derived from the yeast 2 microns plasmid. This successful demonstration of yeast FLP recombinase activity in the mosquito embryo suggests a possible future application of this system in establishing transformed lines of mosquitoes for use in vector control strategies and basic studies.     

DNA Substrates Influence the Recombination Efficiency Mediated by FLP Recombinase Expressed in Mammalian Cells

The FLP recombinase derived from Saccharomyces cerevisiae mediates precise site‐specific recombination between a pair of FLP recognition targets (FRTs). Like the Cre/loxP system derived from bacteriophage P1, the FLP/FRT system has recently been applied to gene regulation systems using an FLP‐expressing recombinant adenovirus (rAd) (Nakano et al, Nucleic Acids Res. 29: e40, 2001). In an attempt to improve the FLP/FRT system by altering its DNA substrates, we compared the recombination efficiency among different substrates by a quantitative in vitro assay using FLP expressed in mammalian cells. Unexpectedly, we found that one linearized DNA substrate showed 4‐ to > 20‐fold lower recombination efficiency than other substrates, which phenomenon has not been observed in the Cre/loxP system. The quantitative in vitro assay using truncated DNA substrates suggested that the recombination efficiency seemed to be influenced not only by the linearized position of the substrate, but also by the length between a pair of FRTs. Such substrate preference of FLP expressed in mammalian cells should probably be noted when designing versatile applications of the FLP/FRT system as a gene regulation system in mammalian systems. Fortunately, however, we demonstrated that no substrate preference was observed when using a particular substrate (pCAFNF5) and the preference was reduced when using a certain pair of mutant FRTs (f72), which will also be a promising tool for simultaneous gene regulation in combination with wild‐type FRT.     

Identification of the crossover site during FLP-mediated recombination in the Saccharomyces cerevisiae plasmid 2 microns circle.

The FLP protein of the Saccharomyces cerevisiae plasmid 2 microns circle catalyzes site-specific recombination between two repeated segments present on the plasmid. In this paper we present results of experiments we performed to define more precisely the features of the FLP recognition target site, which we propose to designate FRT, and to determine the actual recombination crossover point in vivo. We found that essential sequences for the recombination event are limited to an 8-base-pair core sequence and two 13-base-pair repeated units immediately flanking it. This is the region identified as the FLP binding site in vitro and at which FLP protein promotes specific single-strand cleavages (B. J. Andrews, G. A. Proteau, L. G. Beatty, and P. D. Sadowski, Cell 40:795-803, 1985; J. F. Senecoff, R. C. Bruckner, and M. M. Cox, Proc. Natl. Acad. Sci. USA 82:7270-7274, 1985). Mutations within the core domain can be suppressed by the presence of the identical mutation in the chromatid with which it recombines. However, mutations outside the core are not similarly suppressed. We found that strand exchange during FLP recombination occurs most of the time within the core region, proceeding through a heteroduplex intermediate. Finally, we found that most FLP-mediated events are reciprocal exchanges and that FLP-catalyzed gene conversions occur at low frequency. The low level of gene conversion associated with FLP recombination suggests that it proceeds by a breakage-joining reaction and that the two events are concerted.     

In-frame deletion of Escherichia coli essential genes in complex regulon

A conditional knockout-rescue system was developed to construct an in-frame deletion strain ofEscherichia coli essential genes. The target was flanked with marker genes and FRT (FLP recognition target) sites, and a plasmid containing arabinose-induced FLP recombinase was transformed. After arabinose induction, cells could survive only when target protein activity was provided in trans. We selected three essential genes as targets, yaeT, fabZ, and dnaE, which are components of the complex eight-gene regulon yaeT-hlpA-lpxD-fabZ-lpxA-1pxB-rnhB-dnaE. Deletion of these three genes exhibit no polar effects on their adjacent genes in terms of cell viability, meaning that this system not only allows for the simplified study of protein interactions and homolog screening in other organisms, but also facilitates the null mutant construction of essential genes.